Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Polycystic Ovary Syndrome × Exercise Test × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 6 Colorectal Neoplasms 5 Lung Neoplasms 4 Prostatic Neoplasms 3 Motor Activity 2 Hodgkin Disease 2 Hematopoietic and Lymphoid System Neoplasm 2 Urinary Bladder Neoplasms 1 Sleep Wake Disorders 1 Sedentary Behavior 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycystic Ovary Syndrome 1 Pathologically Proven Gastrointestinal Malignancy 1 Obesity 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Insulin Resistance 1 Inflammatory Breast Neoplasms 1 Hematopoietic and Lymphatic System Neoplasm 1 Head and Neck Neoplasms 1 Fatigue 1 FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma 1 Depression 1 Colonic Neoplasms 1 Clinical Stage I Esophageal Adenocarcinoma American Joint Committee on Cancer (AJCC) v8 1 Cardiotoxicity 1

Interventions

Metformin 46 Inositol 20 Clomiphene 16 Letrozole 15 Exercise 11 Folic Acid 9 Caloric Restriction 9 High-Intensity Interval Training 8 Ethinyl Estradiol 8 Progesterone 7 Estradiol 6 Diet 6 drospirenone 5 drospirenone and ethinyl estradiol combination 4 Tablets 4 In Vitro Oocyte Maturation Techniques 4 Diet, Mediterranean 4 Cyproterone Acetate 4 Control Groups 4 Berberine 4 Acupuncture Therapy 4 Triptorelin Pamoate 3 Thioctic Acid 3 Spironolactone 3 Resistance Training 3 Medroxyprogesterone Acetate 3 Flutamide 3 Estrogens 3 Dydrogesterone 3 Diet Therapy 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05215223 2023-10-17

WBV

Cairo University

Phase NA Completed

Insulin Resistance, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡